Apotex Inc.:企業の戦略的SWOT分析

【英語タイトル】Apotex Inc. - Strategic SWOT Analysis Review

GlobalDataが出版した調査資料(GDPH6309SA)・商品コード:GDPH6309SA
・発行会社(調査会社):GlobalData
・発行日:2016年2月4日
・ページ数:33
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:カナダ
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD125 ⇒換算¥13,625見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD375 ⇒換算¥40,875見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Apotex Inc. – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Apotex Inc. (Apotex) is a pharmaceutical company that carries out the production and marketing of a wide range of generic pharmaceuticals. It also undertakes the research, development, manufacturing and distribution of non-prescription and private label medicines, fine chemicals and disposable plastics for medicinal use. The company focuses on providing an array of affordable medicines to patients, healthcare providers, payers and governments worldwide. The company operates through affiliates in Canada, Mexico, the US, Belgium, Czech Republic, the Netherlands, Poland, Spain, Australia, India, New Zealand, Saudi Arabia and Turkey

Apotex Inc. Key Recent Developments

Oct 15,2015 Federal Court judge slams Conservative Government and Minister of Health in the Apotex Judgment
Mar 16,2015 Apotex announces realignment and executive leadership team to better serve the healthcare market in Canada and globally
Jan 30,2015 FDA Issues Warning Letter To Apotex Research

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 – About the Company 6
Apotex Inc. – Key Facts 6
Apotex Inc. – Key Employees 7
Apotex Inc. – Key Employee Biographies 8
Apotex Inc. – Major Products and Services 9
Apotex Inc. – Pharmaceutical Pipeline Products Data 11
Apotex Inc., Pipeline Products by Therapy Area 11
Apotex Inc., Pipeline Products by Development Phase 12
Apotex Inc. – History 14
Apotex Inc. – Company Statement 17
Apotex Inc. – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Section 2 – Company Analysis 20
Apotex Inc. – Business Description 20
Apotex Inc. – Corporate Strategy 21
Apotex Inc. – SWOT Analysis 22
SWOT Analysis – Overview 22
Apotex Inc. – Strengths 22
Strength – Dominant Market Position 22
Strength – Global Network 22
Strength – Strong In-house Research Capabilities 22
Apotex Inc. – Weaknesses 23
Weakness – Product Recalls 23
Apotex Inc. – Opportunities 24
Opportunity – Resuming Shipping to the US 24
Opportunity – Strategic Initiatives 24
Apotex Inc. – Threats 25
Threat – Stringent Government Regulations 25
Threat – Competitive Generic Drug Market 25
Threat – Uncertain R&D Outcomes 25
Apotex Inc. – Key Competitors 26
Section 3 – Company’s Lifesciences Financial Deals and Alliances 27
Apotex Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 27
Apotex Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 28
Apotex Inc., Recent Deals Summary 29
Section 4 – Company’s Recent Developments 30
Oct 15, 2015: Federal Court judge slams Conservative Government and Minister of Health in the Apotex Judgment 30
Mar 16, 2015: Apotex announces realignment and executive leadership team to better serve the healthcare market in Canada and globally 31
Jan 30, 2015: FDA Issues Warning Letter To Apotex Research 32
Section 5 – Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Apotex Inc., Key Facts 6
Apotex Inc., Key Employees 7
Apotex Inc., Key Employee Biographies 8
Apotex Inc., Major Products and Services 9
Apotex Inc., Number of Pipeline Products by Therapy Area 11
Apotex Inc., Number of Pipeline Products by Development Stage 12
Apotex Inc., Pipeline Products By Therapy Area and Development Phase 13
Apotex Inc., History 14
Apotex Inc., Other Locations 18
Apotex Inc., Subsidiaries 18
Apotex Inc., Key Competitors 26
Apotex Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 27
Apotex Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 28
Apotex Inc., Recent Deals Summary 29

List of Figures
Apotex Inc., Pipeline Products by Therapy Area 11
Apotex Inc., Pipeline Products by Development Phase 12
Apotex Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 27
Apotex Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 28

★調査レポート[Apotex Inc.:企業の戦略的SWOT分析] (コード:GDPH6309SA)販売に関する免責事項を必ずご確認ください。
★調査レポート[Apotex Inc.:企業の戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆